Cairo – Mubasher: The financial indicators of Kahira Pharmaceuticals Co. for June 2016 revealed an increase of around 244% in the company’s net profits.
The drug firm stated ,in a bourse statement, that its profits reached EGP 6.2 million ($696,000) in June 2016, compared with EGP 1.8 million ($202,000) for the same comparable period of the previous year.
Meanwhile, the company saw pre tax profits of EGP 5.7 million in June 2016, up from EGP 4.8 million for the same period of the preceding year.
The company’s gross sales stood at EGP 39.6 million in June 2016, against EGP 34 million for the same month of 2015.
